Poly Medicure Limited has announced the approval of its unaudited financial results for the second quarter and half-year ended September 30, 2026. The Board of Directors also identified Poly Medicure B.V., Netherlands, as a material subsidiary, based on its net worth exceeding 10% of the company’s consolidated net worth. The company confirmed compliance with SEBI (LODR) Regulations.
Poly Medicure Announces Financial Results and Subsidiary Status
Poly Medicure Limited has announced the outcome of its Board of Directors’ meeting held on November 5, 2026. The Board approved the unaudited financial results, both standalone and consolidated, for the second quarter and half-year ended September 30, 2026. This includes the approval of the financial results and the associated Auditors’ Review Reports.
Material Subsidiary Identified
In a significant disclosure, the company also identified Poly Medicure B.V., Netherlands, as a material subsidiary. This classification is in accordance with Regulation 16(1)(c) read with Regulation 24 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The identification was based on the subsidiary’s net worth exceeding 10% of the company’s consolidated net worth. Poly Medicure Limited will now ensure compliance with all applicable regulatory requirements pertaining to material subsidiaries.
Meeting Details
The Board meeting commenced at 11:30 AM and concluded at 2:00 PM.
Source: BSE
